Business

July 16, 2014

Pozen resubmits new drug application

Chapel Hill drugmaker Pozen announced Wednesday that federal regulators have accepted the resubmission of its new drug application for its heart attack and stroke-prevention pill.

Related content

Comments

Videos

Editor's Choice Videos